title: Panitumumab as a possible cause of hematospermia: what is the mechanism?
authors.affiliation: Diskapi Education & Research Hospital, Department of Medical Oncology, Ankara, Turkey.
authors.forename: Fatih
authors.initials: F
authors.lastname: Karatas
authors.affiliation: Diskapi Education & Research Hospital, Department of Medical Oncology, Ankara, Turkey.
authors.forename: Suleyman
authors.initials: S
authors.lastname: Sahin
authors.affiliation: Diskapi Education & Research Hospital, Department of Medical Oncology, Ankara, Turkey.
authors.forename: Göksen Inanc
authors.initials: GI
authors.lastname: Imamoglu
authors.affiliation: Diskapi Education & Research Hospital, Department of Medical Oncology, Ankara, Turkey.
authors.forename: Mustafa
authors.initials: M
authors.lastname: Altinbas
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000378:metabolism; D051516:Hemospermia / Q000209:etiology* / Q000378:metabolism; D006801:Humans; D008297:Male; D009092:Mucous Membrane / Q000187:drug effects / Q000378:metabolism; D000077544:Panitumumab
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000077544:Panitumumab; D066246:ErbB Receptors
keywords: EGFR; bleeding; chemotherapy; colon cancer; hematospermia; panitumumab; recurrent; urogenital